Cargando…
Metabolic engineering of Escherichia coli for high-level production of violaxanthin
BACKGROUND: Xanthophylls are a large class of carotenoids that are found in a variety of organisms and play particularly important roles in the light-harvesting and photoprotection processes of plants and algae. Violaxanthin is an important plant-derived xanthophyll with wide potential applications...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283192/ https://www.ncbi.nlm.nih.gov/pubmed/37344799 http://dx.doi.org/10.1186/s12934-023-02098-y |
_version_ | 1785061256743354368 |
---|---|
author | Xinrui, Dong Bo, Liu Yihong, Bao Weifeng, Liu Yong, Tao |
author_facet | Xinrui, Dong Bo, Liu Yihong, Bao Weifeng, Liu Yong, Tao |
author_sort | Xinrui, Dong |
collection | PubMed |
description | BACKGROUND: Xanthophylls are a large class of carotenoids that are found in a variety of organisms and play particularly important roles in the light-harvesting and photoprotection processes of plants and algae. Violaxanthin is an important plant-derived xanthophyll with wide potential applications in medicines, foods, and cosmetics because of its antioxidant activity and bright yellow color. To date, however, violaxanthins have not been produced using metabolically engineered microbes on a commercial scale. Metabolic engineering for microbial production of violaxanthin is hindered by inefficient synthesis pathway in the heterologous host. We systematically optimized the carotenoid chassis and improved the functional expression of key enzymes of violaxanthin biosynthesis in Escherichia coli. RESULTS: Co-overexpression of crtY (encoding lycopene β-cyclase), crtZ (encoding β-carotene 3-hydroxylase), and ZEP (encoding zeaxanthin epoxidase) had a notable impact on their functions, resulting in the accumulation of intermediate products, specifically lycopene and β-carotene. A chassis strain that did not accumulate the intermediate was optimized by several approaches. A promoter library was used to optimize the expression of crtY and crtZ. The resulting strain DZ12 produced zeaxanthin without intermediates. The expression of ZEP was further systematically optimized by using DZ12 as the chassis host. By using a low copy number plasmid and a modified dithiol/disulfide system, and by co-expressing a full electron transport chain, we generated a strain producing violaxanthin at about 25.28 ± 3.94 mg/g dry cell weight with decreased byproduct accumulation. CONCLUSION: We developed an efficient metabolically engineered Escherichia coli strain capable of producing a large amount of violaxanthin. This is the first report of a metabolically engineered microbial platform that could be used for the commercial production of violaxanthin. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12934-023-02098-y. |
format | Online Article Text |
id | pubmed-10283192 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102831922023-06-22 Metabolic engineering of Escherichia coli for high-level production of violaxanthin Xinrui, Dong Bo, Liu Yihong, Bao Weifeng, Liu Yong, Tao Microb Cell Fact Research BACKGROUND: Xanthophylls are a large class of carotenoids that are found in a variety of organisms and play particularly important roles in the light-harvesting and photoprotection processes of plants and algae. Violaxanthin is an important plant-derived xanthophyll with wide potential applications in medicines, foods, and cosmetics because of its antioxidant activity and bright yellow color. To date, however, violaxanthins have not been produced using metabolically engineered microbes on a commercial scale. Metabolic engineering for microbial production of violaxanthin is hindered by inefficient synthesis pathway in the heterologous host. We systematically optimized the carotenoid chassis and improved the functional expression of key enzymes of violaxanthin biosynthesis in Escherichia coli. RESULTS: Co-overexpression of crtY (encoding lycopene β-cyclase), crtZ (encoding β-carotene 3-hydroxylase), and ZEP (encoding zeaxanthin epoxidase) had a notable impact on their functions, resulting in the accumulation of intermediate products, specifically lycopene and β-carotene. A chassis strain that did not accumulate the intermediate was optimized by several approaches. A promoter library was used to optimize the expression of crtY and crtZ. The resulting strain DZ12 produced zeaxanthin without intermediates. The expression of ZEP was further systematically optimized by using DZ12 as the chassis host. By using a low copy number plasmid and a modified dithiol/disulfide system, and by co-expressing a full electron transport chain, we generated a strain producing violaxanthin at about 25.28 ± 3.94 mg/g dry cell weight with decreased byproduct accumulation. CONCLUSION: We developed an efficient metabolically engineered Escherichia coli strain capable of producing a large amount of violaxanthin. This is the first report of a metabolically engineered microbial platform that could be used for the commercial production of violaxanthin. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12934-023-02098-y. BioMed Central 2023-06-21 /pmc/articles/PMC10283192/ /pubmed/37344799 http://dx.doi.org/10.1186/s12934-023-02098-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Xinrui, Dong Bo, Liu Yihong, Bao Weifeng, Liu Yong, Tao Metabolic engineering of Escherichia coli for high-level production of violaxanthin |
title | Metabolic engineering of Escherichia coli for high-level production of violaxanthin |
title_full | Metabolic engineering of Escherichia coli for high-level production of violaxanthin |
title_fullStr | Metabolic engineering of Escherichia coli for high-level production of violaxanthin |
title_full_unstemmed | Metabolic engineering of Escherichia coli for high-level production of violaxanthin |
title_short | Metabolic engineering of Escherichia coli for high-level production of violaxanthin |
title_sort | metabolic engineering of escherichia coli for high-level production of violaxanthin |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283192/ https://www.ncbi.nlm.nih.gov/pubmed/37344799 http://dx.doi.org/10.1186/s12934-023-02098-y |
work_keys_str_mv | AT xinruidong metabolicengineeringofescherichiacoliforhighlevelproductionofviolaxanthin AT boliu metabolicengineeringofescherichiacoliforhighlevelproductionofviolaxanthin AT yihongbao metabolicengineeringofescherichiacoliforhighlevelproductionofviolaxanthin AT weifengliu metabolicengineeringofescherichiacoliforhighlevelproductionofviolaxanthin AT yongtao metabolicengineeringofescherichiacoliforhighlevelproductionofviolaxanthin |